New York State Common Retirement Fund Outlook Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$0.22 - $0.66 $78 - $234	-356 Reduced 0.97%	36,263 $14,000
Q3 2023 Nov 07, 2023	BUY	$0.2 - $1.78 $82 - $729	410 Added 1.13%	36,619 $8,000
Q2 2023 Aug 07, 2023	BUY	$1.02 - $1.89 $294 - $546	289 Added 0.8%	36,209 $63,000
Q4 2022 Jan 30, 2023	SELL	$0.87 - $1.33 $137 - $210	-158 Reduced 0.44%	35,920 $39,000
Q3 2022 Nov 08, 2022	BUY	$1.02 - $1.26 $312 - $385	306 Added 0.86%	36,078 $44,000

Q2 2022 Aug 04, 2022	BUY	$0.91 - $2.01 $31 - $70	35 Added 0.1%	35,772 $36,000
Q4 2021 Feb 02, 2022	SELL	$1.27 - $2.23 $186 - $327	-147 Reduced 0.41%	35,737 $49,000
Q3 2021 Nov 02, 2021	SELL	$2.12 - $2.76 $82,925 - $107,960	-39,116 Reduced 52.15%	35,884 $78,000
Q2 2021 Aug 02, 2021	BUY	$1.78 - $2.76 $133,500 - $206,999	75,000 New	75,000 $187,000

67.1K

Ticker OTLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,144,992
Market Cap $1.6B
Description
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.